JOHN WOLF to Treatment Outcome
This is a "connection" page, showing publications JOHN WOLF has written about Treatment Outcome.
Connection Strength
0.119
-
Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair. Int J Dermatol. 2007 Jan; 46(1):94-8.
Score: 0.021
-
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea. Cutis. 2007 Jan; 79(1):73-80.
Score: 0.021
-
Safety and tolerability in the MORE trial. Cutis. 2006 Jul; 78(1 Suppl):19-25.
Score: 0.021
-
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. Cutis. 2006 Apr; 77(4 Suppl):3-11.
Score: 0.020
-
Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol. 2004 Jul-Aug; 3(4):401-7.
Score: 0.018
-
Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003 Sep; 49(3 Suppl):S211-7.
Score: 0.017